This post-translational modification stabilizes MYC mRNA, thereby contributing to the progression of pancreatic cancer.252 These findings highlight YTHDF3 as a key factor in the regulation of cancer development and progression, underscoring its potential as a therapeutic target. Here, YTHDF3 is linked to familial pancreatic carcinoma.